hotspot -WSS

hotspot

author：leisure time 2025-08-26 03:42:34 - browse：9758

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Study: Black kids more likely to die after surgery than white kids

WSS

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Florida Supreme Court upholds state's abortion ban

Mass General Brigham physicians react to latest merger step

Global cancer cases to surge 77% by 2050, WHO report says

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Updated Covid vaccine has 54% effectiveness, new study suggests

Wikipedia

hotspot

explore

23andMe had bad news about my health. I wish a person had delivered it

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Bernie brings in new pharma CEOs to talk drug prices

Malaria cases in Florida and Texas: Here’s what you need to know

Oral obesity drug from Viking Therapeutics hits key early target

ChatGPT in medicine: STAT answers readers' burning questions

Scientific mystery highlights the blind spots in genomics databases

What does generative AI mean for health care? We asked experts

Scientific mystery highlights the blind spots in genomics databases

Wikipedia

U.K. decision on ALS drug has neurologists, advocates up in arms

Gut bacteria may contribute to kidney autoimmunity, study finds

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

340B reform proposal comes out of Senate working group

What’s missing from the debate over nursing home staff minimums

hotspot

leisure time

Wikipedia

leisure time